ERG, ETS transcription factor (ERG) Peptide
Quick Overview for ERG, ETS transcription factor (ERG) Peptide (ABIN976422)
Target
Origin
Source
Application
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-ERG antibody (Catalog #: P100625_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- ERG (ERG, ETS transcription factor (ERG))
-
Background
-
V-ets erythroblastosis virus E26 oncogene like isoform 2 (ERG) is a transcriptional regulator. It may participate in transcriptional regulation through the recruitment of SETDB1 histone methyltransferase and subsequent modification of local chromatin structure.
Alias Symbols: p55, erg-3
Protein Interaction Partner: ERG,ETS2,ETV1,FLI1,JUN,SETDB1,SPI1,ETS2,JUN
Protein Size: 462 -
Molecular Weight
- 52 kDa
-
Gene ID
- 2078
-
NCBI Accession
- NM_004449, NP_004440
-
UniProt
- P11308
Target
-